Home / Health / FDA Suspends Cooper Hospital Blood Bank License
FDA Suspends Cooper Hospital Blood Bank License
5 Nov
Summary
- Cooper Hospital's PPP blood bank license suspended for two days.
- Suspension is due to lack of proper documentation found by FDA.
- Hospital will rely on another blood bank during the two-day suspension.
The license for the public-private-partnership blood bank at Cooper Hospital has been suspended by the food and drug administration (FDA) for two days. The suspension commenced on November 5, 2026, and is scheduled to end at midnight on November 7, 2026.
According to FDA officials, the notice for this action was served 90 days prior. A key reason cited for the suspension was the lack of proper documentation at the blood bank, which is operated by Samarprit Bahuddeshiya Sevabhavi Vikas Sanstha.
During the two-day suspension, Cooper Hospital will utilize the services of the blood bank located at Trauma Hospital in Jogeshwari. This situation echoes recent FDA actions against blood banks at JJ Hospital and Nair Hospital, where similar interventions occurred following events involving donor gifts at a blood donation drive.
